share_log

EyePoint Pharmaceuticals | 4: Statement of changes in beneficial ownership of securities-Director Lurker Nancy

SEC ·  Jul 27 04:49
Summary by Futu AI
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Nancy Lurker, a person associated with the company. The transaction, which took place on July 26, 2024, did not specify the relationship of Nancy Lurker to the issuer. Details regarding the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement.
EyePoint Pharmaceuticals, Inc. (EYPT) has reported a transaction involving Nancy Lurker, a person associated with the company. The transaction, which took place on July 26, 2024, did not specify the relationship of Nancy Lurker to the issuer. Details regarding the number of shares, nature of the shares, transaction price, and post-transaction holdings were not disclosed in the announcement.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated